TrialSkeletal muscle2026

Evaluation of a serum protein signature as monitoring biomarker for Duchenne muscular dystrophy in a long-term clinical trial with corticosteroids.

Chiara Degan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.